Effects of Ginkgo biloba on plasma oxidant injury induced by bleomycin in rats
- PMID: 16572711
- DOI: 10.1191/0748233706th245oa
Effects of Ginkgo biloba on plasma oxidant injury induced by bleomycin in rats
Abstract
Bleomycin is an anti-neoplastic agent and its clinical usage is limited by its toxicity, which is mostly induced by oxygen radicals. The aim of this study was to investigate the effect of Ginkgo biloba on plasma indices of oxidants induced by bleomycin in rats. Male Sprague-Dawley rats were divided into five groups: none medicated or 0.9% NaCl injected or only Ginkgo biloba (orally, 100 mg/kg per day for 14 days) or only a single dose of bleomycin (intratracheal, 2.5 U/kg) or Gingko biloba and bleomycin-treated groups. After 14 days, blood was taken before the rats were sacrificed. The plasma was removed and stored at -85 degrees C until the study day. Plasma superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and xanthine oxidase (XO) enzyme activities with malondialdehyde and nitric oxide (NO) levels were studied. The levels of malondialdehyde and NO with activity of XO were higher in plasma of bleomycin group than the other groups (P <0.05). The activities of SOD and GSH-Px were increased in the bleomycin plus Gingko biloba group in comparison with the bleomycin group (P <0.05). There was a positive correlation between malondialdehyde and NO levels in the bleomycin group (r =0.859, P <0.05). There were positive correlations between SOD and GSH-Px activities (r =0.760, P <0.05) and between XO activity and malondialdehyde level (r =0.822, P <0.05) in the bleomycin plus Gingko biloba group. In conclusion, it was thought that bleomycin induced oxidative stress can be prevented by Gingko biloba treatment via high anti-oxidant enzyme activity together with decreased radical production from XO.
Similar articles
-
Effects of oral Ginkgo biloba supplementation on cataract formation and oxidative stress occurring in lenses of rats exposed to total cranium radiotherapy.Jpn J Ophthalmol. 2004 Sep-Oct;48(5):499-502. doi: 10.1007/s10384-004-0101-z. Jpn J Ophthalmol. 2004. PMID: 15486777
-
The effects of ginkgo biloba extract on tissue adenosine deaminase, xanthine oxidase, myeloperoxidase, malondialdehyde, and nitric oxide in cisplatin-induced nephrotoxicity.Toxicol Ind Health. 2006 Apr;22(3):125-30. doi: 10.1191/0748233705th255oa. Toxicol Ind Health. 2006. PMID: 16716042
-
Protective effects of Ginkgo biloba extract in rats with hypoxia/reoxygenation-induced intestinal injury.J Pediatr Surg. 2011 Apr;46(4):685-690. doi: 10.1016/j.jpedsurg.2010.09.053. J Pediatr Surg. 2011. PMID: 21496538
-
Ginkgo biloba and the central nervous system.Fitoterapia. 2000 Aug;71 Suppl 1:S43-7. doi: 10.1016/s0367-326x(00)00180-5. Fitoterapia. 2000. PMID: 10930712 Review.
-
Neuroprotective Potential of Ginkgo biloba in Retinal Diseases.Planta Med. 2019 Nov;85(17):1292-1303. doi: 10.1055/a-0947-5712. Epub 2019 Jul 2. Planta Med. 2019. PMID: 31266069 Review.
Cited by
-
Oxytocin alleviates cisplatin-induced renal damage in rats.Iran J Basic Med Sci. 2014 Oct;17(10):747-52. Iran J Basic Med Sci. 2014. PMID: 25729542 Free PMC article.
-
Protective effect of a novel antifungal peptide derived from human chromogranin a on the immunity of mice infected with Candida krusei.Exp Ther Med. 2017 May;13(5):2429-2434. doi: 10.3892/etm.2017.4290. Epub 2017 Mar 30. Exp Ther Med. 2017. PMID: 28565859 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical